Vancomycin-Resistant enterococcus faecium bacteremia: Risk factors for infection

Clinical Infectious Diseases

Volumn 20, Issue 5, 1995, Pages 1126-1133

  Edmond, Michael B ^a,b,c,d,e,f   Ober, Janis F ^a,b,c,d,e,f   Weinbaum, David L ^a,b,c,d,e,f   Pfaller, Michael A ^a,b,c,d,e,f   Hwang, Taekyu ^a,b,c,d,e,f   Sanford, Melissa D ^a,b,c,d,e,f   Wenzel, Richard P ^a,b,c,d,e,f  

^a Clinical Epidemiology and Health Services Research   (United States)

^b Department of Pathology ^*  (United States)

^c Division of Biostatistics   (United States)

^d UNIVERSITY OF IOWA   (United States)

^e UNIVERSITY OF IOWA HOSPITALS AND CLINICS   (United States)

^f WESTERN PENNSYLVANIA HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; CLINDAMYCIN; IMIPENEM; METRONIDAZOLE; TEICOPLANIN; VANCOMYCIN;

ADULT; AGED; ANTIBIOTIC RESISTANCE; ARTICLE; BACTEREMIA; CLINICAL ARTICLE; ENTEROCOCCUS FAECALIS; FEMALE; HUMAN; INFECTION RISK; MALE; MORTALITY; PRIORITY JOURNAL; STREPTOCOCCUS INFECTION;

ADULT; AGED; BACTEREMIA; CASE-CONTROL STUDIES; CROSS INFECTION; DISEASE OUTBREAKS; DRUG RESISTANCE, MICROBIAL; ENTEROCOCCUS FAECIUM; FEMALE; GRAM-POSITIVE BACTERIAL INFECTIONS; HUMAN; MALE; MIDDLE AGE; RISK FACTORS; SUPPORT, U.S. GOV'T, P.H.S.; VANCOMYCIN;

EID: 0028989194     PISSN: 10584838     EISSN: 15376591     Source Type: Journal    
DOI: 10.1093/clinids/20.5.1126     Document Type: Article

References (39)

1. Spera RV jr, Farber BF. Multiply-resistant Enterococcus faecium: the nosocomial pathogen of the 1990s. JAMA 1992;268:2563-64.
2. Emori TG, Gaynes RP. An overview of nosocomial infections, include ing the role of the microbiology laboratory. Clin Microbiol Rev 1993;6:428-42.
3. Banerjee SN, Emori TG, Culver DH et al. Secular trends in nosocomial primary bloodstream infections in the United States, 1980-1989. Am J Med 1991;91 (suppl 3B):86S-9S.
4. CDC. Nosocomial enterococci resistant to vancomycin-United States, 1989-1993. MMWR Morbid Mortal Wkly Rep 1993; 42:597-9.
5. Tenover FC, Tokars J, Swenson J, Paul S, Spitalny K, Jarvis W. Ability of clinical laboratories to detect antimicrobial agent-resistant enterococci. J Clin Microbiol 1993;31:1695-9.
6. National Committee for Clinical Laboratory Standards. Performance standards for antimicrobial disk susceptibility tests. Approved standard M2-A5. Villanova, PA: National Committee for Clinical Laboratory Standards, 1993.
7. Arthur M, Courvalin P. Genetics and mechanisms of glycopeptide resis tance in enterococci. Antimicrob Agents Chemother 1993; 37:1563-71.
8. Doebbeling BN, Pfaller MA, Houston AK, Wenzel RP. Removal of nosocomial pathogens from the contaminated glove: implications for glove reuse and handwashing. Ann Intern Med 1988; 109:394-8.
9. Murray BE, Singh KV, Heath JD, Sharma BR, Weinstock GM. Compar ison of genomic DNAs of different enterococcal isolates using restric-tion endonucleases with infrequent recognition sites. J Clin Microbiol 1990;28:2059-63.
10. Willey BM. McGeer AJ. Ostrowski MA, Kreiswirth BN, Low DE. The use of molecular typing techniques in the epidemiologic investigation of resistant enterococci. Infect Control Hosp Epidemiol 1994; 15:548-56.
11. Goering RV. Molecular epidemiology of nosocomial infection: analysis of chromosomal restriction fragment patterns by pulsed-field electrophoresis. Infect Control Hospital Epidemiol 1993; 14:595-600.
12. Bingen EH, Denamur E, Lambert-Zechovsky NY, Elion J. Evidence for the genetic unrelatedness of nosocomial vancomycin-resistant Enter- ococcus faecium strains in a pediatric hospital. J Clin Microbiol 1991;29:1888-92.
13. Rubin LG, Tucci V, Cercenado E, Eliopoulos G, Isenberg HD. Vanco mycin-resistant Enlerococcus faecium in hospitalized children. Infect Control Hosp Epidemiol 1992; 13:700-5.
14. Boyle JF, Soumakis SA, Rendo A, et al. Epidemiologic analysis and genotypic characterization of a nosocomial outbreak of vancomycin- resistant enterococci. J Clin Microbiol 1993;31:1280-5.
15. Baillie LWJ, Wade JJ, Casewell MW. Chlorhexidene sensitivity of En lerococcus faecium resistant to vancomycin, high levels of gentami- cin, or both. J Hosp Infect 1992;20:127-8.
16. Wade JJ, Desai N, Casewell MW. Hygienic hand disinfection for the removal of epidemic vancomycin-resistant Enlerococcus faecium and gentamicin-resistant Enlerobacler cloacae. J Hosp Infect 1991; 18:211-8.
17. Mayo JW, Wenzel RP. Rates of hospital-acquired bloodstream infec tions in patients with specific maligtiancy. Cancer 1982;50:187-90.
18. Garrison RN, Fry DE, Berberich S, Polk HC, Jr. Enterococcal bacter emia: clinical implications and determinants of death. Ann Surg 1982; 196:43-7.
19. Klimek JJ, Ajemian E, Gracewski J, et al. Enterococcal infections in alarge community hospital, with emphasis on bacteremia. Am J Infect Control 1980;8:58-61.
20. Dougherty SH, Flohr AB, Simmons RL. “Breakthrough” enterococcalsepticemia in surgical patients: 19 cases and a review of the literature. Arch Surg 1983;1 18:232-8.
21. Maki DG, Agger WA. Enterococcal bacteremia: clinical features, therisk of endocarditis, and management. Medicine (Baltimore) 1988; 67:248-69.
22. Holm SE. Gram-positive microorganisms in sepsis. Scand J Infect Dis1982; 31 (suppl):68-77.
23. Landry SL, Kaiser DL, Wenzel RP. Hospital stay and mortality attrib uted to nosocomial enterococcal bacteremia: a controlled study. Am J Infect Control 1989; 17:323-9.
24. Zervos MJ, Kauffman CA, Therasse PM, Bergman AG, Mikesell TS, Schaberg DR. Nosocomial infection by gentamicin-resistant Streptococcus faecalis: an epidemiologic study. Ann Intern Med 1987; 106:687-91.
25. Karanfil LV, Murphy M, Josephson A, et al. A cluster of vancomycin- resistant Enlerococcus faecium in an intensive care unit. Infect Control Hosp Epidemiol 1992; 13:195-200.
26. Livornese LL Jr. Dias S, Samel C, et al. Hospital-acquired infection with vancomycin-resistant Enlerococcus faecium transmitted by electronic thermometers. Ann Intern Med 1992; 117:112-6.
27. Handwerger S, Raueher B, Altarac D, et al. Nosocomial outbreak due to Enlerococcus faecium highly resistant to vancomycin, penicillin, and gentamicin. Clin Infect Dis 1993; 16:750-5.
28. Montecalvo MA, Horowitz H, Gedris C, et al. Outbreak of vancomy cin-, ampicillin-, and aminoglycoside-resistant Enlerococcus faecium bacteremia in an adult oncology unit. Antimicrob Agents Chemother 1994;38:1363-7.
29. Boyce JM, Opal SM, Chow JW et al. Outbreak of multidrug-resistant Enlerococcus faecium with transferable vanB class vancomycin resistance. J Clin Microbiol 1994;32:1148-53.
30. Yu VL. Enterococcal superinfection and colonization after therapy with moxalactam, a new broad-spectrum antibiotic. Ann Intern Med 1981;94:784-5.
31. Moellering RC, Jr. Enterococcal infections in patients treated with moxalactam. Rev Infect Dis 1982;S708-11.
32. Thomas CT, Berk SL, Thomas E. Enterococcal liver abscess associated with moxalactam therapy: review of literature on enterococcal superinfections in association with moxalactam therapy. Arch Intern Med 1983;143:1780-1.
33. Wilson WR, Henry NK, Keys TF, et al. Empiric therapy with moxalac tam alone in patients with bacteremia. Mayo Clin Proc 1984; 59:318-26.
34. Feliciano DV, Gentry LO, Bitondo CG, et al. Single agent cephalospo rin prophylaxis for penetrating abdominal trauma: results and comment on the emergence of the enterococcus. Am J Surg 1986; 152:674-81.
35. Sexton DJ, Harrell LJ, Thorpe JJ, Hunt DL, Reller LB. A case-control study of nosocomial ampicillin-resistant enterococcal infection and colonization at a university hospital. Infect Control Hosp Epidemiol 1993;14:629-35.
36. Boyce JM, Opal SM, Potter-Bynoe G, et al. Emergence and nosocomial transmission of ampicillin-resistant enterococci. Antimicrob Agents Chemother 1992;36:1032-9.
37. Pallares R, Dick R, Wenzel RP, Adams JR, Nettleman MD. Trends in antimicrobial utilization at a tertiary teaching hospital during a 15- year period (1978-1992). Infect Control Hosp Epidemiol 1993; 14:376-82.
38. Ena J, Dick RW, Jones RN, Wenzel RP. The epidemiology of intrave nous vancomycin usage in a university hospital: a 10-year study. JAMA 1993;269:598-602.
39. Doebbeling BN, Stanley GL, Sheetz CT, et al. Comparative efficacy of alternative hand-washing agents in reducing nosocomial infections in intensive care units. New Engl J Med 1992;327:88-93.